140 research outputs found

    Thalidomide before autologous stem cell transplantation in VAD-refractory multiple myeloma patients

    No full text
    We used thalidomide to treat 10 patients with advanced stage multiple myeloma who had failed to obtain at least a partial response after a VAD-based induction therapy. Seven out 10 cases achieved clinical and histologic responses and proceeded to collection of peripheral blood stem cells and transplantation and ASCT

    P-glycoprotein (PGP), lung resistance-related protein (LRP) and multidrug resistance-associated protein (MRP) expression in acute promyelocytic leukaemia

    No full text
    corecore